![](/img/cover-not-exists.png)
Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway
Zhu, Jing, Xin, Ying, Liu, Xiaoliang, Wang, Ying, Liu, YingLanguage:
english
Journal:
Experimental and Therapeutic Medicine
DOI:
10.3892/etm.2018.5856
Date:
February, 2018
File:
PDF, 1.40 MB
english, 2018